Company Filing History:
Years Active: 2020
Title: Durgarao Kantheti: Innovator in Pharmaceutical Compounds
Introduction
Durgarao Kantheti is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds that have potential therapeutic applications.
Latest Patents
Durgarao Kantheti holds a patent for "Heteroaryl substituted aminopyridine compounds." This patent discloses compounds of Formula (I) or salts thereof, wherein HET is a heteroaryl selected from oxazolyl, pyrazolyl, imidazo[1,2-b]pyridazin-3-yl, and pyrazolo[1,5-a]pyrimidin-3-yl. The heteroaryl is attached to the pyridinyl group in the compound of Formula (I) by a carbon ring atom in the heteroaryl and is substituted with zero to 2 R. The patent also outlines methods of using such compounds as modulators of IRAK4, and pharmaceutical compositions comprising these compounds. These compounds are useful in treating, preventing, or slowing inflammatory and autoimmune diseases, or in the treatment of cancer. Durgarao Kantheti has 1 patent to his name.
Career Highlights
Durgarao Kantheti is currently employed at Bristol-Myers Squibb Company, where he continues to work on innovative pharmaceutical solutions. His expertise in the field has positioned him as a valuable asset to the company and the industry at large.
Collaborations
Throughout his career, Durgarao has collaborated with esteemed colleagues, including John V Duncia and Daniel S Gardner. These collaborations have further enhanced his research and development efforts in the pharmaceutical sector.
Conclusion
Durgarao Kantheti is a prominent inventor whose work in pharmaceutical compounds has the potential to impact the treatment of various diseases. His contributions to the field exemplify the importance of innovation in healthcare.